These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31226715)

  • 1. EPG5 Variants with Modest Functional Impact Result in an Ameliorated and Primarily Neurological Phenotype in a 3.5-Year-Old Patient with Vici Syndrome.
    Kane MS; Zhao J; Muskett J; Diplock A; Srivastava S; Hauser N; Deeken JF; Niederhuber JE; Smith WE; Vilboux T; Ebrahimi-Fakhari D
    Neuropediatrics; 2019 Aug; 50(4):257-261. PubMed ID: 31226715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autopsy findings in EPG5-related Vici syndrome with antenatal onset.
    Touraine R; Laquerrière A; Petcu CA; Marguet F; Byrne S; Mein R; Yau S; Mohammed S; Guibaud L; Gautel M; Jungbluth H
    Am J Med Genet A; 2017 Sep; 173(9):2522-2527. PubMed ID: 28748650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel compound heterozygous EPG5 mutations consisted with a missense mutation and a microduplication in the exon 1 region identified in a Japanese patient with Vici syndrome.
    Shimada S; Hirasawa K; Takeshita A; Nakatsukasa H; Yamamoto-Shimojima K; Imaizumi T; Nagata S; Yamamoto T
    Am J Med Genet A; 2018 Dec; 176(12):2803-2807. PubMed ID: 30152144
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EPG5-related Vici syndrome: a paradigm of neurodevelopmental disorders with defective autophagy.
    Byrne S; Jansen L; U-King-Im JM; Siddiqui A; Lidov HG; Bodi I; Smith L; Mein R; Cullup T; Dionisi-Vici C; Al-Gazali L; Al-Owain M; Bruwer Z; Al Thihli K; El-Garhy R; Flanigan KM; Manickam K; Zmuda E; Banks W; Gershoni-Baruch R; Mandel H; Dagan E; Raas-Rothschild A; Barash H; Filloux F; Creel D; Harris M; Hamosh A; Kölker S; Ebrahimi-Fakhari D; Hoffmann GF; Manchester D; Boyer PJ; Manzur AY; Lourenco CM; Pilz DT; Kamath A; Prabhakar P; Rao VK; Rogers RC; Ryan MM; Brown NJ; McLean CA; Said E; Schara U; Stein A; Sewry C; Travan L; Wijburg FA; Zenker M; Mohammed S; Fanto M; Gautel M; Jungbluth H
    Brain; 2016 Mar; 139(Pt 3):765-81. PubMed ID: 26917586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low-level expression of EPG5 leads to an attenuated Vici syndrome phenotype.
    Waldrop MA; Gumienny F; Boue D; de Los Reyes E; Shell R; Weiss RB; Flanigan KM
    Am J Med Genet A; 2018 May; 176(5):1207-1211. PubMed ID: 29681093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ophthalmic findings as clues for early diagnosis of Vici syndrome in a neonate.
    Rafei MA; Harikrishna B; Al Thihli K; Al-Mujaini AS; Ganesh A
    Ophthalmic Genet; 2021 Dec; 42(6):780-783. PubMed ID: 34264147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The first Chinese case of Vici syndrome with novel compound heterozygous sequence variants in EPG5.
    Dong L; Li L; Zhang X; Xu X; Han M; Liu S
    Int J Dev Neurosci; 2021 Dec; 81(8):706-716. PubMed ID: 34405433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phenotypic expansion of EGP5-related Vici syndrome: 15 Dutch patients carrying a founder variant.
    Vansenne F; Fock JM; Stolte-Dijkstra I; Meiners LC; van den Boogaard MH; Jaeger B; Boven L; Vos YJ; Sinke RJ; Verbeek DS
    Eur J Paediatr Neurol; 2022 Nov; 41():91-98. PubMed ID: 36410285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First description of a patient with Vici syndrome due to a mutation affecting the penultimate exon of EPG5 and review of the literature.
    Ehmke N; Parvaneh N; Krawitz P; Ashrafi MR; Karimi P; Mehdizadeh M; Krüger U; Hecht J; Mundlos S; Robinson PN
    Am J Med Genet A; 2014 Dec; 164A(12):3170-5. PubMed ID: 25331754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vici syndrome with pathogenic homozygous EPG5 gene mutation: A case report and literature review.
    Abidi KT; Kamal NM; Bakkar AA; Almarri S; Abdullah R; Alsufyani M; Alharbi A
    Medicine (Baltimore); 2020 Oct; 99(43):e22302. PubMed ID: 33120733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vici Syndrome with a Novel Mutation in EPG5.
    Moirangthem A; Mandal K; Ghosh A; Phadke SR
    Indian Pediatr; 2019 Jul; 56(7):603-605. PubMed ID: 31333218
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal and postnatal presentations of corpus callosum agenesis with polymicrogyria caused by EGP5 mutation.
    Maillard C; Cavallin M; Piquand K; Philbert M; Bault JP; Millischer AE; Moshous D; Rio M; Gitiaux C; Boddaert N; Masson C; Thomas S; Bahi-Buisson N
    Am J Med Genet A; 2017 Mar; 173(3):706-711. PubMed ID: 28168853
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EPG5-Related Vici Syndrome: A Primary Defect of Autophagic Regulation with an Emerging Phenotype Overlapping with Mitochondrial Disorders.
    Balasubramaniam S; Riley LG; Vasudevan A; Cowley MJ; Gayevskiy V; Sue CM; Edwards C; Edkins E; Junckerstorff R; Kiraly-Borri C; Rowe P; Christodoulou J
    JIMD Rep; 2018; 42():19-29. PubMed ID: 29159459
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two cases of Vici syndrome presenting with corpus callosum agenesis, albinism, and severe developmental delay.
    Hızal M; Yeke B; Yıldız Y; Öztürk A; Gürbüz BB; Coşkun T
    Turk J Pediatr; 2020; 62(3):474-478. PubMed ID: 32558422
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defects in autophagosome-lysosome fusion underlie Vici syndrome, a neurodevelopmental disorder with multisystem involvement.
    Hori I; Otomo T; Nakashima M; Miya F; Negishi Y; Shiraishi H; Nonoda Y; Magara S; Tohyama J; Okamoto N; Kumagai T; Shimoda K; Yukitake Y; Kajikawa D; Morio T; Hattori A; Nakagawa M; Ando N; Nishino I; Kato M; Tsunoda T; Saitsu H; Kanemura Y; Yamasaki M; Kosaki K; Matsumoto N; Yoshimori T; Saitoh S
    Sci Rep; 2017 Jun; 7(1):3552. PubMed ID: 28615637
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recessive mutations in EPG5 cause Vici syndrome, a multisystem disorder with defective autophagy.
    Cullup T; Kho AL; Dionisi-Vici C; Brandmeier B; Smith F; Urry Z; Simpson MA; Yau S; Bertini E; McClelland V; Al-Owain M; Koelker S; Koerner C; Hoffmann GF; Wijburg FA; ten Hoedt AE; Rogers RC; Manchester D; Miyata R; Hayashi M; Said E; Soler D; Kroisel PM; Windpassinger C; Filloux FM; Al-Kaabi S; Hertecant J; Del Campo M; Buk S; Bodi I; Goebel HH; Sewry CA; Abbs S; Mohammed S; Josifova D; Gautel M; Jungbluth H
    Nat Genet; 2013 Jan; 45(1):83-7. PubMed ID: 23222957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscle pathology in Vici syndrome-A case study with a novel mutation in EPG5 and a summary of the literature.
    Hedberg-Oldfors C; Darin N; Oldfors A
    Neuromuscul Disord; 2017 Aug; 27(8):771-776. PubMed ID: 28624465
    [TBL] [Abstract][Full Text] [Related]  

  • 18. EPG5 c.1007A > G mutation in a sibling pair with rapidly progressing Vici syndrome.
    Vojcek E; Keszthelyi TM; Jávorszky E; Balogh L; Tory K
    Ann Hum Genet; 2020 Jan; 84(1):80-86. PubMed ID: 31184778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The
    Meneghetti G; Skobo T; Chrisam M; Facchinello N; Fontana CM; Bellesso S; Sabatelli P; Raggi F; Cecconi F; Bonaldo P; Dalla Valle L
    Autophagy; 2019 Aug; 15(8):1438-1454. PubMed ID: 30806141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EPG5 Compound Heterozygous Unreported Pathogenic Variants in a Mexican Patient with Vici Syndrome.
    Rodríguez-Morales M; Liquidano-Perez E; Garza-Mayén G; Bustamante-Montes LP; Villarroel-Cortés C
    J Clin Immunol; 2022 Jul; 42(5):952-954. PubMed ID: 35389122
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.